The TOGETHER Study Shows that Fluvoxamine Reduces Risk of Prolonged Hospitalization

Fluvoxamine Reduces Hospitalization Risk in High-Risk Patients (1 Minute Journal Club-ish) #shortsПодробнее

Fluvoxamine: a $4 Antidepressant That Reduces COVID 19 HospitalizationsПодробнее

Could Fluvoxamine Work as COVID Treatment?Подробнее

Antidepressant reduces hospitalisations and deathsПодробнее

Study Shows Widely-Available Antidepressant Significantly Reduces COVID HospitalizationПодробнее

HealthWatch: Research Finds Fluvoxamine Cut Hospital Admissions For COVID-19 PatientsПодробнее

Update on Fluvoxamine - Encouraging Study!Подробнее

How does Luvox (fluvoxamine) work? #shortsПодробнее

Some antidepressants may lower risk of severe illness from COVID-19, study findsПодробнее

When the optimal time to take Luvox is! #Short #medicalexpertПодробнее

New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19Подробнее

Common Antidepressant Likely Cuts Risk Of Covid Hospitalization StudyПодробнее

Fluvoxamine and inflammation in Covid-19Подробнее

Can we use a depression treatment drug to treat COVID? What do we know so far?Подробнее

In-Depth: With COVID therapies scarce, studies suggest a common pill has promiseПодробнее

Fluvoxamine (Luvox) What you NEED to Know! #antidepressantsПодробнее

$4 antidepressant shows promise against early COVID-19 symptoms; more study neededПодробнее

Daily Covid-19 Minute: FluvoxamineПодробнее

Researchers say one type of antidepressant could help with COVID-19 symptomsПодробнее